Galapagos NV
SWB:GXEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galapagos NV
SWB:GXEA
|
BE |
|
U
|
United Labels AG
XBER:ULC
|
DE |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
ID |
|
Roche Holding AG
F:RHO
|
CH |
|
B
|
B.P. Marsh & Partners PLC
XBER:B5V
|
UK |
|
ABB India Ltd
NSE:ABB
|
IN |
|
C
|
Cellectis SA
SWB:ZVAA
|
FR |
|
APi Group Corp
F:4XY
|
US |
|
BYD Co Ltd
SZSE:002594
|
CN |
|
Uxin Ltd
NASDAQ:UXIN
|
CN |
|
A
|
Arch Resources Inc
SWB:ACCA
|
US |
|
B
|
Bayer AG
F:BAYN
|
DE |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
|
R
|
Range Resources Corp
DUS:RAX
|
US |
|
Vaxart Inc
OTC:VXRT
|
US |
|
V
|
Vishal Mega Mart Ltd
NSE:VMM
|
IN |
|
Evli Oyj
F:V6O
|
FI |
|
C
|
Carlsberg A/S
XMUN:CBGB
|
DK |
|
F
|
Flexible Solutions International Inc
AMEX:FSI
|
CA |
Bankruptcy Probability
Galapagos NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Galapagos NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Galapagos NV
AEX:GLPG
|
1.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Galapagos NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Galapagos NV has total debt of 5.2m EUR. This includes both short-term (0 EUR) and long-term (5.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
